A 584 bp deletion in CTRB2 inhibits chymotrypsin B2 activity and secretion and confers risk of pancreatic cancer

Ashley Jermusyk, Jun Zhong, Katelyn E. Connelly, Naomi Gordon, Sumeth Perera, Ehssan Abdolalizadeh, Tongwu Zhang, Aidan O’Brien, Jason W. Hoskins, Irene Collins, Daina Eiser, Chen Yuan, Demetrius Albanes, Alan A. Arslan, Aurelio Barricarte Gurrea, Laura E. Beane Freeman, Paige M. Bracci, Bas Bueno‐de‐Mesquita, Julie E. Buring, Federico Canzian, S Gallinger, J. Michael Gaziano, Graham G. Giles, Phyllis J. Goodman, Mattias Johansson, Charles Kooperberg, Loı̈c Le Marchand, Núria Malats, Rachel Ε. Neale, Salvatore Panico, Ulrike Peters, Francisco X. Real, Xiao‐Ou Shu, Malin Sund, M. Thornquist, Anne Tjønneland, Ruth C. Travis, Stephen K. Van Den Eeden, Kala Visvanathan, Wei Zheng, Peter Kraft, Harvey A. Risch, Eric J. Jacobs, Donghui Li, Mengmeng Du, Rachael Z. Stolzenberg‐Solomon, Alison P. Klein, Jill P. Smith, Brian M. Wolpin, Stephen J. Chanock, Jianxin Shi, Gloria M. Petersen, Christopher J. Westlake, Laufey T. Ámundadóttir